Application of nanotechnology to target and exploit tumour associated proteases

Area of Science:

• Biochemistry
• Oncology
• Nanotechnology

Background:

• Proteases are vital enzymes, but their dysregulation drives cancer development and progression.
• Current protease inhibitors face clinical challenges like toxicity and poor drug delivery.
• Nanotechnology presents novel strategies to address these limitations in cancer therapy.

Purpose of the Study:

• To review preclinical advancements in nanomedicine for protease drug delivery.
• To examine the use of tumor-derived proteases for nanomedicine targeting.
• To assess the therapeutic and diagnostic potential of nanomedicine in protease-related diseases.

Main Methods:

• Literature review of preclinical studies on nanomedicine and proteases.
• Analysis of strategies for enhancing protease drug delivery using nanoparticles.
• Examination of methods exploiting tumor proteases for targeted nanomedicine.

Main Results:

• Nanotechnology-based approaches show promise in improving protease inhibitor delivery.
• Exploiting tumor protease activity can enhance nanomedicine targeting to cancer sites.
• Preclinical data suggest significant potential for nanomedicine in protease-targeted cancer therapy.

Conclusions:

• Nanomedicine offers innovative solutions to overcome challenges in protease inhibitor therapy.
• Targeting proteases via nanomedicine holds promise for improved cancer treatment and diagnostics.
• Further research is needed as this field is still in its early stages.